| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 9e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |